Search results for "N-2"

showing 10 items of 1881 documents

Ruthenium‐assisted tellurium abstraction in bis(thiophen‐2‐yl) ditelluride

2023

The reaction of [RuCl2(CO)3]2 and Te2Tpn2 (Tpn = thiophen-2-yl, C4H3S) in the absence of light resulted in the formation of cct-[RuCl2(CO)2(TeTpn2)2] (1) [cis(Cl)-cis(CO)-trans(TeTpn2)] and TeTpn2 (2) together with the precipitation of tellurium. The complex 1 and the monotelluride 2 were characterized by NMR spectroscopy and single-crystal X-ray diffraction. The decomposition of Te2Tpn2 to TeTpn2 has been monitored by 125Te NMR spectroscopy and seemed to be faster than the ligand substitution in [RuCl2(CO)3]2 by TeTpn2. A catalytic cycle is proposed for the decomposition of Te2Tpn2 to TeTpn2 based on the PBE0-D3/def2-TZVP calculations. peerReviewed

Inorganic Chemistrycrystal structurestelluuriBis(thiophen-2-yl) ditellanedicarbonyldichloridobis[bis(thiophen-2-yl)tellane]rutheniumreaction pathwaykompleksiyhdisteetorganometalliyhdisteettellurium abstraction
researchProduct

β1D Integrin Inhibits Cell Cycle Progression in Normal Myoblasts and Fibroblasts

1998

Integrins are alphabeta heterodimeric transmembrane receptors involved in the regulation of cell growth and differentiation. The beta1 integrin subunit is widely expressed in vivo and is represented by four alternatively spliced cytoplasmic domain isoforms. beta1D is a muscle-specific variant of beta1 integrin and a predominant beta1 isoform in striated muscles. In the present study we showed that expression of the exogenous beta1D integrin in C2C12 myoblasts and NIH 3T3 or REF 52 fibroblasts inhibited cell proliferation. Unlike the case of the common beta1A isoform, adhesion of beta1D-transfected C2C12 myoblasts specifically via the expressed integrin did not activate mitogen-activated pro…

IntegrinsRecombinant Fusion ProteinsMolecular Sequence DataIntegrinSignal transductionTransfectionCell adhesion; Integrins; Signal transduction; Alternative splicing isoforms; Cell proliferation; MyodifferentiationBiochemistryCD49cCell LineCollagen receptorMiceAlternative splicing isoformsCell surface receptorAnimalsAmino Acid SequenceMuscle SkeletalMolecular BiologyCell proliferationMyodifferentiationbiologyCell growthIntegrin beta1Cell CycleCell adhesionCell DifferentiationReceptors Interleukin-2Cell BiologyImmunohistochemistryMolecular biologyCell biologyEnzyme ActivationProto-Oncogene Proteins c-rafAlternative SplicingGenes rasIntegrin alpha MCalcium-Calmodulin-Dependent Protein Kinasesbiology.proteinIntegrin beta 6C2C12Journal of Biological Chemistry
researchProduct

Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4…

2004

Down-regulation of autoreactive T cell responses in vivo includes cell-contact-dependent as well as contact-independent mechanisms. Infectious tolerance is a contact-dependent mechanism used by naturally occurring CD25(+) T regulatory cells (Tregs) to confer suppressive activity upon conventional CD4(+) T cells thereby generating secondary T helper suppressor cells(Th(sup)), which inhibit T cell activation via soluble mediators. Here, we describe two distinct subsets of human Tregs, characterized by expression of either the alpha(4)beta(7) integrin or the alpha(4)beta(1) integrin. Upon activation, both subsets show an enhanced expression of FoxP3, recently described as a key transcription f…

IntegrinsbiologyT cellImmunologyIntegrinFOXP3Receptors Interleukin-2T lymphocyteT-Lymphocytes Helper-InducerCell biologyInterleukin-10Interleukin 21medicine.anatomical_structureT-Lymphocyte SubsetsTransforming Growth Factor betaImmunologymedicinebiology.proteinImmunology and AllergyCytotoxic T cellHumansIL-2 receptorBeta (finance)European journal of immunology
researchProduct

Induction of accessory cell function of human alveolar macrophages by inhalation of human natural interleukin-2.

1996

Accessory function allows antigen-presenting cells to produce sufficient secondary signals for optimum T cell proliferation and interleukin-2 (IL-2) production. Alveolar macrophages are inferior accessory cells compared to monocytes (PBM). We report here that the accessory index (AI) of alveolar macrophages and PBM of patients with lung metastases of solid tumors treated with inhalations of human natural IL-2 (hnIL-2) increased following its administration (P0.005). The accessory index was significantly elevated from baseline values after 2 weeks of inhalation of 300,000 IU hnIL-2/day (8.2 +/- 10.2 compared to 1.1 +/- 1; P0.001). The inhalation of 150,000 IU also induced increases in the in…

Interleukin 2AdultCancer Researchmedicine.medical_specialtyLung Neoplasmsmedicine.medical_treatmentImmunologyAntigen-Presenting CellsInternal medicineAdministration InhalationMacrophages AlveolarmedicineImmunology and AllergyHumansAntigen-presenting cellCarcinoma Renal CellAgedLungmedicine.diagnostic_testInhalationbusiness.industryMonocyteMiddle AgedKidney NeoplasmsEndocrinologyCytokineBronchoalveolar lavagemedicine.anatomical_structureCarcinoma BronchogenicOncologyEvaluation Studies as TopicImmunologyInterleukin-2Pulmonary alveolusbusinessBronchoalveolar Lavage Fluidmedicine.drugCancer immunology, immunotherapy : CII
researchProduct

Estimation of the frequency of self-reactive T cells in health and inflammatory diseases by limiting dilution analysis and single cell cloning.

1996

Autoreactive T cells have recently been detected not only in autoimmune diseases but also in healthy individuals, but their frequency is thought to be low. The aim of our study was to estimate the frequency of self-reactive T cells by using limiting dilution analyses of peripheral blood lymphocytes. Assessment of self-reactivity in this study was defined as T-cell proliferation to autologous non-T cells in the absence of foreign antigens. When culture conditions were optimized by adding interleukin 2, healthy individuals showed a frequency of self-reactive T cells ranging from 1/60 to 1/600. These results were confirmed by using unseparated peripheral blood leukocytes or Epstein-Barr virus …

Interleukin 2AdultMaleAdolescentmedicine.medical_treatmentT-LymphocytesImmunologyInterleukin 21AntigenmedicineImmunology and AllergyCytotoxic T cellHumansLymphocyte CountInflammationbiologybusiness.industryT lymphocyteMiddle AgedClone CellsCytokineImmunologyInterleukin 12biology.proteinInterleukin-2FemaleInterleukin-4Antibodybusinessmedicine.drugJournal of autoimmunity
researchProduct

A phase-II study of low-dose cyclophosphamide and recombinant human interleukin-2 in metastatic renal cell carcinoma and malignant melanoma.

1989

Recent preclinical and clinical studies that have demonstrated antitumor activity of high-dose recombinant interleukin-2 (rIL-2), and animal models that demonstrated a synergistic effect of low-dose cyclophosphamide, led us to study rIL-2 (Cetus Corp., Emeryville, Calif) in a phase II clinical trial in combination with low-dose cyclophosphamide in 32 patients, 18 with malignant melanoma and 14 with renal cell carcinoma. rIL-2 was given once daily at 3 x 10(6) U/m2, as a 30-min infusion for 14 days in cycle I and for 2 x 5 days in cycles II and III respectively; if tolerated, the dose was increased to a maximum of 6 x 10(6) U m-2 day-1; the cycles, separated by 1 week treatment-free interval…

Interleukin 2AdultMaleCancer Researchmedicine.medical_specialtyPathologyCyclophosphamidemedicine.medical_treatmentImmunologyPhases of clinical researchGastroenterologyDrug Administration ScheduleRenal cell carcinomaInternal medicineAntineoplastic Combined Chemotherapy ProtocolsImmunology and AllergyMedicineHumansNeoplasm MetastasisCyclophosphamideMelanomaAgedChemotherapyKidneybusiness.industryMelanomaCarcinomaRemission InductionReceptors Interleukin-2Middle Agedmedicine.diseaseKidney NeoplasmsRecombinant ProteinsBlood Cell Countmedicine.anatomical_structurePhenotypeOncologyDrug EvaluationInterleukin-2FemaleBolus (digestion)businessmedicine.drugCancer immunology, immunotherapy : CII
researchProduct

Abnormalities in serum concentrations of interleukin-2, interferon-alpha and interferon-gamma in schizophrenia not detected.

1992

The hypothesis of an immunological defect in schizophrenia has been supported by reports on abnormal production of interleukin-2 (IL-2) and interferons (IFNs) in schizophrenic patients. In the present study we determined the serum concentrations of IL-2, IFN-alpha and IFN-gamma in 10 first onset, neuroleptic-naive schizophrenics, in 6 pretreated patients who were drug free (1 week to 2 years) at the time of the investigation and in 15 matched healthy controls. No IFN-alpha was detected in schizophrenics' and in control sera. No differences were found in IL-2 and IFN-gamma levels between schizophrenics and controls. Thus the present study failed to support the hypothesis of an immunological …

Interleukin 2AdultMalePsychosisAlpha interferonInterferon-gammaReference ValuesInterferon αmedicineImmune ToleranceHumansInterferon gammaBiological PsychiatryInterferon alfaPsychiatric Status Rating ScalesSchizophrenia Paranoidbusiness.industryInterferon-alphaSerum concentrationmedicine.diseasePsychiatry and Mental healthSchizophreniaImmunologySchizophreniaInterleukin-2FemaleSchizophrenic Psychologybusinessmedicine.drugSchizophrenia research
researchProduct

Analysis of impaired in vitro immunoglobulin synthesis in rheumatoid arthritis.

1990

Decreased immunoglobulin production in pokeweed mitogen driven lymphocyte cultures has been reported in rheumatoid arthritis (RA). Here various activators and experimental designs have been used to determine the contribution of B cells, T cells, or monocytes to this low response. Sixty patients with RA and paired controls were studied at the onset of disease and again six months later. Concentrations of IgA, IgG, and IgM in cultures of RA peripheral blood mononuclear cells stimulated with thymus dependent activators were already decreased at the onset of the disease. Six months later RA mononuclear cells produced even lower concentrations of immunoglobulin. In contrast, stimulation with a T…

Interleukin 2AdultMalemedicine.medical_specialtyAdolescentLymphocyteT cellImmunologyImmunoglobulin ELymphocyte ActivationPeripheral blood mononuclear cellT-Lymphocytes RegulatoryGeneral Biochemistry Genetics and Molecular BiologyMonocytesArthritis RheumatoidRheumatologyInternal medicinemedicineImmunology and AllergyHumansCells CulturedAgedbiologybusiness.industryMonocytePokeweed mitogenT-Lymphocytes Helper-InducerMiddle AgedImmunoglobulin Isotypesmedicine.anatomical_structureEndocrinologyImmunologybiology.proteinInterleukin-2FemaleAntibodybusinessmedicine.drugResearch Article
researchProduct

The effect of age on mitogen responsive T cell precursors in human beings is completely restored by interleukin-2.

1992

Abstract It is well known that the function of T lymphocytes is significantly impaired by advancing age. In the present study, attempts have been made to further characterize the T cell impairment of elderly subjects. Thus, we have performed limiting dilution microculture analysis to evaluate the precursor frequency of T lymphocytes responding to a mitogenic stimulus in old and young subjects. Furthermore we have evaluated the activity of recombinant interleukin-2 (rIL-2) on these cells. The results demonstrate that in older subjects the frequency of these precursors is significantly decreased. The in vitro treatment with rIL-2 increased the frequency of mitogen responsive T lymphocyte prec…

Interleukin 2AdultMalemedicine.medical_specialtyAgingmedicine.medical_treatmentT cellT-LymphocytesIn Vitro TechniquesLymphocyte ActivationInternal medicinemedicineConcanavalin AHumansAgedAged 80 and overbiologyCell growthT lymphocyteMiddle AgedHematopoietic Stem CellsIn vitroEndocrinologyCytokinemedicine.anatomical_structureConcanavalin AAgeingImmunologybiology.proteinInterleukin-2FemaleDevelopmental Biologymedicine.drugMechanisms of ageing and development
researchProduct

Uremic serum inhibits monocyte-dependent, but not interleukin-2-dependent steps of T cell proliferation.

1990

We examined the influence of uremic serum on antigen receptor triggered T cell proliferation in dialysis patients with impaired immune function, i.e., 12 nonresponders to hepatitis B vaccination. The dialysis patients showed a monocyte dysfunction and an increased responsiveness to interleukin 2 (IL-2) according to our previous findings. In vitro the addition of IL-2 completely reconstituted the defect. Uremic serum inhibited monocyte-dependent T cell proliferation of patients and of healthy controls. Contrary, monocyte-independent steps of T cell proliferation were not impaired by uremic serum. When IL-2 was added to cultures, the T cell proliferation in the presence of uremic serum was ev…

Interleukin 2AdultMalemedicine.medical_specialtyT cellT-LymphocytesLymphocyte ActivationMonocytesImmune toleranceImmune systemInternal medicinemedicineImmune ToleranceSuppressor Factors ImmunologicHumansAgedUremiabusiness.industryCell growthMonocyteT lymphocyteMiddle Agedmedicine.diseaseUremiamedicine.anatomical_structureEndocrinologyInterleukin-2businessmedicine.drugNephron
researchProduct